Clinical characteristics of a COVID-19 cohort treated at UCLA Ronald Reagan Medical Center during the breaking phase of the pandemic: A retrospective study

By sjmartinez • July 11, 2024

Zhou B, Zong NC, Zhang Y, Huang Y, Youn JY, Cai H. Clinical characteristics of a COVID-19 cohort treated at UCLA Ronald Reagan Medical Center during the breaking phase of the pandemic: A retrospective study. Redox Biol. 2024 Jul 2;75:103178. doi: 10.1016/j.redox.2024.103178. Epub ahead of print. PMID: 38986245.

Age, Anti-virals, Antibiotics, Body mass index, BMI, COVID‐19, California, Census, Coagulation, Demography, Ethnicities, Gender, Immunosuppressants, Inflammation, Intensive care/intensive care unit, Los Angeles, Obesity, Pandemic, Public health, Ronald Reagan Medical Center, SARS-COV-2, Smoking, Steroids, University of California Los Angeles, UCLA,

Tags: age, Anti-virals, antibiotics, BMI, body mass index, California, Cardiology/Epi, Census, Coagulation, COVID‐19, Demography, Ethnicities, gender, Immunosuppressants, Inflammation, Intensive care/intensive care unit, Los Angeles, Obesity, Pandemic, Post Doc, public health, Publications, Ronald Reagan Medical Center, SARS-CoV-2, smoking, steroids, UCLA, University of California Los Angeles

Novel Virtual Reality Intervention for Stress Reduction Among Patients With or at Risk for Cardiovascular Disease: Mixed Methods Pilot Study

Makaroff KE, Van C, Grospe V, Edmunds L, Calfon-Press MA, Watson KE, Horwich T. Novel Virtual Reality Intervention for Stress Reduction Among Patients With or[...]

Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve replacement

Liu Z, Aguayo E, Porter G, Ali K, Zinoviev R, Benharash P. Association of hematological malignancies with clinical and financial outcomes following transcatheter aortic valve[...]

Design and rationale of a randomized clinical trial assessing the effect of inclisiran on atherosclerotic plaque in individuals without previous cardiovascular event and without flow- limiting lesions identified in an in-hospital screening – The VICTORION-PLAQUE primary prevention trial

Revaiah PC, Serruys PW, Onuma Y, Andreini D, Budoff MJ, Sharif F, Chernofsky A, Vikarunnessa S, Wiethoff AJ, Yates D, Achouba A. Design and rationale[...]